Jill Daley practises intellectual property, regulatory and commercial law as a barrister and solicitor. In addition, Ms. Daley is a licensed and practising pharmacist in Ontario with experience in community pharmacy, long-term care, addiction treatment and consulting.
She has experience in a wide range of matters involving the innovative pharmaceutical, biotechnology, natural health product, medical device and cosmetic industries, including pre-clinical and clinical trial applications, packaging, labelling, advertising and marketing practices, submissions and responses to the Common Drug Review and the Patented Medicine Prices Review Board, provincial listing agreements, formulary listing, interchangeability decisions under Ontario’s Drug Interchangeability and Dispensing Fee Act and Ontario Drug Benefit Act as well as proceedings under the Patented Medicines (Notice of Compliance) Regulations. As part of her practice, Ms. Daley advises on the practice of regulated health professionals in Ontario.
Ms. Daley’s counsel to clients includes developing industry-specific compliance programs, document management, and third-party responses to access requests. She advises clients on various privacy issues pursuant to the federal Personal Information Protection and Electronic Documents Act as well as provincial legislation pertaining to personal information and personal health information.
Ms. Daley advises on all aspects of advertising and marketing law for consumer products, including advertisement review (print, broadcast and internet), review of contests, coupon and premium promotions, packaging and labelling requirements, comparative claim and advertising support. Ms. Daley also includes representing clients in trade dispute proceedings administered by Advertising Standards Canada and the Pharmaceutical Advertising Advisory Board.
As part of her practice, Ms. Daley helps clients deal with regulatory and pre-clearance agencies, such as Health Canada, the Health Products and Food Branch Inspectorate, the Patented Medicine Prices Review Board, the Ontario Public Drug Plans, the Pharmaceutical Advertising Advisory Board, the Canadian Agency for Drugs and Technology and the Office of Information and Privacy Commissioner/Ontario as well as advising on judicial review of these agencies’ decisions.